Buglioni S - Search Results

1

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.

Melucci E, Casini B, Ronchetti L, Pizzuti L, Sperati F, Pallocca M, De Nicola F, Goeman F, Gallo E, Amoreo CA, Sergi D, Terrenato I, Vici P, Di Lauro L, Diodoro MG, Pescarmona E, Barba M, Mazzotta M, Mottolese M, Fanciulli M, Ciliberto G, De Maria R, Buglioni S, Maugeri-Saccà M. Melucci E, et al. Among authors: buglioni s. J Transl Med. 2018 Feb 5;16(1):22. doi: 10.1186/s12967-018-1385-y. J Transl Med. 2018. PMID: 29402328 Free PMC article.

2

Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.

Buglioni S, D'Agnano I, Cosimelli M, Vasselli S, D'Angelo C, Tedesco M, Zupi G, Mottolese M. Buglioni S, et al. Int J Cancer. 1999 Dec 22;84(6):545-52. doi: 10.1002/(sici)1097-0215(19991222)84:6<545::aid-ijc1>3.0.co;2-2. Int J Cancer. 1999. PMID: 10567896 Free article.

3

Prognostic relevance of altered Fas (CD95)-system in human breast cancer.

Mottolese M, Buglioni S, Bracalenti C, Cardarelli MA, Ciabocco L, Giannarelli D, Botti C, Natali PG, Concetti A, Venanzi FM. Mottolese M, et al. Among authors: buglioni s. Int J Cancer. 2000 Mar 20;89(2):127-32. doi: 10.1002/(sici)1097-0215(20000320)89:2<127::aid-ijc5>3.0.co;2-4. Int J Cancer. 2000. PMID: 10754489 Free article.

4

Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

Mottolese M, Benevolo M, Del Monte G, Buglioni S, Papaldo P, Nisticò C, Di Filippo F, Vasselli S, Vici P, Botti C. Mottolese M, et al. Among authors: buglioni s. J Cancer Res Clin Oncol. 2000 Dec;126(12):722-9. doi: 10.1007/pl00008478. J Cancer Res Clin Oncol. 2000. PMID: 11153146

5

Polyclonal antibodies against gp185HER2 peptides: their putative role in the identification of a particular HER2 status in patients with breast cancer.

Di Modugno F, Buglioni S, Mottolese M, Bello DD, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: buglioni s. J Immunother. 2001 May-Jun;24(3):221-31. J Immunother. 2001. PMID: 11394499

6

Polyclonal Antibodies Against gp185HER2 Peptides: Their Putative Role in the Identification of a Particular HER2 Status in Patients With Breast Cancer.

Di Modugno F, Buglioni S, Mottolese M, Del Bello D, Cascioli S, Chersi A, Santoni A, Nisticò P. Di Modugno F, et al. Among authors: buglioni s. J Immunother (1991). 2001 May;24(3):221-231. J Immunother (1991). 2001. PMID: 11395637

7

p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy.

Buglioni S, D'Agnano I, Vasselli S, Perrone Donnorso R, D'Angelo C, Brenna A, Benevolo M, Cosimelli M, Zupi G, Mottolese M. Buglioni S, et al. Am J Clin Pathol. 2001 Sep;116(3):360-8. doi: 10.1309/V7UW-UT2E-JVYH-DGWK. Am J Clin Pathol. 2001. PMID: 11554164

8

Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.

Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V. Greco C, et al. Among authors: buglioni s. Anticancer Res. 2001 Sep-Oct;21(5):3185-92. Anticancer Res. 2001. PMID: 11848471

9

Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer.

Cianciulli AM, Botti C, Coletta AM, Buglioni S, Marzano R, Benevolo M, Cione A, Mottolese M. Cianciulli AM, et al. Among authors: buglioni s. Cancer Genet Cytogenet. 2002 Feb;133(1):66-71. doi: 10.1016/s0165-4608(01)00559-3. Cancer Genet Cytogenet. 2002. PMID: 11890992

10

Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.

Botti C, Buglioni S, Benevolo M, Giannarelli D, Papaldo P, Cognetti F, Vici P, Di Filippo F, Del Nonno F, Venanzi FM, Natali PG, Mottolese M. Botti C, et al. Among authors: buglioni s. Clin Cancer Res. 2004 Feb 15;10(4):1360-5. doi: 10.1158/1078-0432.ccr-1092-03. Clin Cancer Res. 2004. PMID: 14977837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page